No Data
No Data
Enlivex Therapeutics Ltd. Receives Approval for Phase I Trial of Allocetra in TMJ Osteoarthritis Patients
Express News | Enlivex Therapeutics Receives Regulatory Authorization From Israeli Ministry Of Health For Initiation Of Phase I Trial Evaluating Allocetra In Patients With TMJ Osteoarthritis
Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating Allocetra in Patients With TMJ Osteoarthritis
Express News | D. Boral Capital Maintains Buy on Enlivex Therapeutics, Maintains $13 Price Target
Express News | Elivex Therapeutics Shares Are Trading Higher After the Company Announced Interim Efficacy Data Showing Statistical Significance and Marked Improvements for Its Allocetra Trial
Enlivex Announces Interim Efficacy Data From Allocetra Trial In Patients With Moderate To Severe Knee Osteoarthritis
Unlock the Full List